Developmental expression and subcellular localization of glutaminyl cyclase in mouse brain

Area of Science:

• Neuroscience
• Biochemistry
• Molecular Biology

Background:

• Glutaminyl cyclase (QC) stabilizes peptides by forming pyroglutamate (pE).
• QC generates pathogenic pE-Abeta in Alzheimer's disease (AD), making it a therapeutic target.
• QC's expression, localization, and developmental roles in the brain are largely unknown.

Purpose of the Study:

• To investigate the expression, cell type-specific localization, and developmental profile of QC in mouse brain and peripheral organs.
• To understand QC's subcellular localization and its implications for protein maturation.
• To explore potential roles of QC in brain regions affected by Alzheimer's disease.

Main Methods:

• Quantitative real-time PCR (qRT-PCR) for QC mRNA expression analysis.
• Immunocytochemistry and immunohistochemistry for QC protein localization in brain.
• Subcellular double immunofluorescence to determine QC's intracellular location.
• Analysis across different developmental stages in mice.

Main Results:

• QC mRNA is highly expressed in hypothalamus, hippocampus, and cortex, with significant levels in liver.
• Developmental analysis shows stable QC mRNA in hypothalamus but a decline in cortex and hippocampus postnatally.
• Immunocytochemistry confirmed QC expression in specific hypothalamic and hippocampal neurons, including GABAergic interneurons.
• QC localizes to the endoplasmic reticulum, Golgi apparatus, and secretory granules, indicating a role in protein processing.

Conclusions:

• QC is widely expressed in the mouse brain, with distinct regional and developmental patterns.
• QC's subcellular localization supports its role in peptide/protein maturation and modification.
• Findings suggest QC's involvement in hypothalamic hormone maturation and potentially in learning/memory processes relevant to Alzheimer's disease.